BMC pledges to fight ResMed’s allegations
BEIJING – Weeks after ResMed announced it won preliminary injunctions in its German patent-infringement case against BMC, the Chinese sleep therapy device maker is pledging to fight. “We will take all the measures required to defend our IP and products, thus protecting our consumer and business interests against the preliminary injunctions,” stated BMC President James Xu in a release. The preliminary injunction that ResMed won did not and could not take BMC’s story into account, according to Ulrich Worm, an attorney retained by BMC. “The court’s decision to grant the preliminary injunction does not mean the court has concluded that BMC’s products infringed the patents,” Worm said. “Until now, no hearing is conducted.” ResMed is pursuing similar legal action in the U.S. BMC has also retained patent specialist Gary Hnath of Mayer Brown to fully contest those proceedings.